Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye
Abstract views: 104
/ 
PDF downloads: 67
DOI:
https://doi.org/10.26900/hsq.2113Keywords:
Attitude, barrier, COVID-19, vaccine, vaccine hesitancyAbstract
This study aimed to determine the barriers, vaccine hesitancy and attitudes towards the to the COVID-19 vaccine in Türkiye. A cross-sectional study included 2031 people aged 18 years and older living in Türkiye. Data were collected through an online questionnaire created by the researchers in line with the literature and the Attitudes towards the COVID-19 Vaccine (ATV-COVID-19) scale. In total, 1043 participants (51.4%) defined themselves as vaccine hesitant. The most-motivating factor for vaccination was protecting self and family, while thinking that vaccines are unsafe was the most common barrier against vaccination. Compared to females, being male (OR=0.770) had a 1.3-times (1/0.770) protective effect from vaccination hesitancy, while one unit increase in the ATV-COVID-19 score (OR=0.080) was 12.5-times (1/0.080) protective. As a result of the study, it was observed that there was a high level of vaccine hesitancy due to mistrust of COVID-19 vaccines or fear of side effects. In addition, vaccine hesitancy was associated with gender and the level of attitude towards the vaccine.
Downloads
References
Tanriverdi G, Yalçın Gürsoy M, Özsezer G. COVID-19 Pandemic from a public health nursing perspective [in Turkish]. Halk Sağlığı Hemşireliği Dergisi 2020;2(2):126-42.
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of Coronavirus (COVID-19). 2021 Sep 2. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
WHO 2020. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
WHO 2021. Strategy to achieve global COVID-19 vaccination by mid-2022. Geneva: World Health Organization; 2021. Available from: https://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf [cited 2021 Oct 6].
Saied SM, Saied EM, Kabbash IA, Abdo SAE. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021;93(7):4280-91. doi:10.1002/jmv.26910.
Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020;50(SI-1):611-9. doi: 10.3906/sag-2004-145.
Shen AK, Lindstrand A, Schreiber B, O'Brien K. Optimizing the supply of vaccines for COVID-19. Bull World Health Organ. 2021;99(12):848-A. doi: 10.2471/BLT.21.287513.
Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52(5):737-41. doi: 10.1016/j.immuni.2020.04.012.
Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245-51. doi: 10.1016/j.puhe.2021.02.025.
Khan YH, Mallhi TH, Alotaibi NH, Alzarea AI, Alanazi AS, Tanveer N, et al. Threat of COVID-19 vaccine hesitancy in Pakistan: The need for measures to neutralize misleading narratives. Am J Trop Med Hyg. 2020;103(2):603–4. doi: 10.4269/ajtmh.20-0654.
Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC Public Health. 2021;21(1):1438. doi: 10.1186/s12889-021-11501-5.
Omar DI, Hani BM. Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults. J Infect Public Health. 2021;14(10):1481-8. doi: 10.1016/j.jiph.2021.06.019.
Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020;19:1-3. doi: 10.1017/S0033291720004067.
İkiışık H, Akif Sezerol M, Taşçı Y, Maral I. COVID-19 vaccine hesitancy: A community-based research in Turkey. Int J Clin Pract. 2021;75(8):e14336. doi: 10.1111/ijcp.14336.
MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036.
Salomoni MG, Di Valerio Z, Gabrielli E, Montalti M, Tedesco D, Guaraldi F, Gori D. Hesitant or not hesitant? A systematic review on global COVID-19 vaccine acceptance in different populations. Vaccines. 2021;9(8):873. doi: 10.3390/vaccines9080873.
Öztürk Çopur E, Karasu F. Thoughts and attitudes of individuals about COVID-19 vaccine. Turkiye Klinikleri J Health Sci. 2021. doi: 10.5336/healthsci.2021-84513
Mahmud S, Mohsin M, Khan IA, Mian AU, Zaman MA. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLoS One. 2021;9;16(9):e0257096. doi: 10.1371/journal.pone.0257096.
Geniş B, Gürhan N, Koç M, Geniş Ç, Şirin B, Çirakoğlu OC, Coşar B. Development of perception and attitude scales related with COVID-19 pandemia. Pearson Journal of Social Sciences-Humanities. 2020;5(7):306-328. doi: 10.46872/pj.127.
Danabal KGM, Magesh SS, Saravanan S, Gopichandran V. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India - a community-based survey. BMC Health Serv Res. 2021;21(1):994. doi: 10.1186/s12913-021-07037-4.
Sallam M. COVID-19 Vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;16;9(2):160. doi: 10.3390/vaccines9020160.
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. doi: 10.1016/j.lanepe.2020.100012.
Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Health. 2021;9:698111. doi: 10.3389/fpubh.2021.698111.
Biswas MR, Alzubaidi MS, Shah U, Abd-Alrazaq AA, Shah Z. A scoping review to find out worldwide COVID-19 vaccine hesitancy and its underlying determinants. Vaccines. 2021; 9(11):1243. doi: 10.3390/vaccines9111243
Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 Vaccine acceptance and hesitancy in low- and middle-income countries, and implications for messaging. medRxiv 2021,1–10. doi: 10.1101/2021.03.11.21253419
Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nature Medicine. 2021;27(8):1338-1339.
Chaudhary FA, Ahmad B, Khalid MD, Fazal A, Javaid MM, Butt DQ. Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population. Hum Vaccin Immunother. 2021;3;17(10):3365-3370. doi: 10.1080/21645515.2021.1944743.
Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine. 2021;40:101113. doi: 10.1016/j.eclinm.2021.101113.
Aw J, Seng JJB, Seah SSY, Low LL. COVID-19 Vaccine hesitancy-a scoping review of literature in high-income countries. Vaccines (Basel). 2021;13;9(8):900. doi: 10.3390/vaccines9080900.
Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020; 35(8):775-779. doi: 10.1007/s10654-020-00671-y.
Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, Zhao Q, Liu J. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: A systematic review and meta-analysis. Aging Clin Exp Res. 2020 Sep;32(9):1869-1878. doi: 10.1007/s40520-020-01664-3.
Berenguer J, Ryan P, Rodríguez-Baño J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020;26(11):1525-1536. doi: 10.1016/j.cmi.2020.07.024
Cordina M, Lauri MA, Lauri J. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine. Pharm Pract (Granada). 2021;19(1):2317. doi:10.18549/PharmPract.2021.1.2317
Schmid P, MacDonald NE, Habersaat K, Butler R. Commentary to: How to respond to vocal vaccine deniers in public. Vaccine. 2018;36(2):196-198. doi: 10.1016/j.vaccine.2016.09.065
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Holistence Publications
This work is licensed under a Creative Commons Attribution 4.0 International License.
When the article is accepted for publication in the HSQ authors transfer all copyright in the article to the Holistence Academy Ar-Ge Yazılım Yayıncılık Eğitim Danışmanlık ve Organizasyon Ticaret Ltd. Şti.The authors reserve all proprietary right other than copyright, such as patent rights.
Everyone who is listed as an author in this article should have made a substantial, direct, intellectual contribution to the work and should take public responsibility for it.
This paper contains works that have not previously published or not under consideration for publication in other journals.
